1 |
Komurcuoglu B, Ulusoy S, Gayaf M, et al (2011). Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori, 97, 743-8.
|
2 |
Levin RD, Daehler MA, Grutsch JF, et al (2010). Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer, 10, 565-72.
DOI
ScienceOn
|
3 |
Oya M, Akiyama Y, Okuyama T, Ishikawa H (2001). High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol, 31, 388-94.
DOI
ScienceOn
|
4 |
Sekhon SS, Roy V (2006). Thrombocytopenia in adults: a practical approach to evaluation and management. South Med J, 99, 491-8.
DOI
ScienceOn
|
5 |
Ten Berg MJ, van den Bent PM, Shantakumar S, et al (2011). Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study. Drug Saf, 34, 1151-60.
DOI
ScienceOn
|
6 |
Wu S, Zhang Y, Xu L, et al (2012). Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy. Support Care Cancer, 20, 1875-84
DOI
|
7 |
Yamamato M, Yoshinaga K, Matsuyama A, et al (2012). Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. Oncology, 83, 10-5.
DOI
ScienceOn
|
8 |
Yashiki C, Hirose T, Sugiyama T, et al (2010). Chemotherapyinduced myelosuppression and treatment efficacy in limitedstage disease small cell lung cancer. Gan To Kagaku Ryoho, 37, 245-9.
|
9 |
Antoniou D, Pavlakou G, Stathopoulos GP, et al (2006). Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer, 53, 205-10.
DOI
ScienceOn
|
10 |
Arnold DM, Lim W (2011). A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient. Semin Hematol, 48, 251-8.
DOI
ScienceOn
|
11 |
Andre T, Boni C, Mounedji-Boudiaf L (2004). Oxaliplatin, fluorouracil, and leucovorin an adjuvant treatment for colon cancer. N Engl J Med, 350, 2343-52.
DOI
ScienceOn
|
12 |
Dirix LY, Salgado R, Weytjens R, et al (2002). Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer, 86, 389-95.
DOI
ScienceOn
|
13 |
Bartucci M, Dattilo R, Martinetti D, et al (2011). Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor. Clin Cancer Res, 17, 6185-91.
DOI
ScienceOn
|
14 |
Blackwell K, Haroon Z, Broadwater G, et al (2000). Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol, 18, 600-8.
|
15 |
Colucci G, Gebbia V, Paoletti G, et al (2005). Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the gruppo oncologica dell'italia meridionale. J Clin Oncol, 23, 4866-75.
DOI
ScienceOn
|
16 |
Edwards CM, Warren J, Armstrong L, Donnelly PK (1993). D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg, 80, 1404-5.
DOI
ScienceOn
|
17 |
Hitron A, Steinke D, Sutphin S, et al (2011). Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors. J Oncol Pharm Pract, 17, 312-9.
DOI
|
18 |
Jelic S, Radulovic S (2006). Chemotherapy-associated thrombocytopenia: current and emerging management strategies. Am J Cancer, 6, 372-82.
|
19 |
Kirwan CC, McDowell G, McCollum CN, Kumar S, Byrne GJ (2008). Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer, 99, 1000-6.
DOI
ScienceOn
|